Early studies suggest that this peptide – a dual stimulator of GLP-1 and GIP receptors – may provide a considerable breakthrough in metabolic loss programs . Unlike existing treatments , this dual-action compound appears to influence hunger and energy burn via separate routes. While further investigation is needed , early data generate optimis